Home/Filings/4/0001209191-22-049469
4//SEC Filing

Wong Hing C 4

Accession 0001209191-22-049469

CIK 0001828673other

Filed

Sep 11, 8:00 PM ET

Accepted

Sep 12, 3:05 PM ET

Size

6.0 KB

Accession

0001209191-22-049469

Insider Transaction Report

Form 4
Period: 2022-09-08
Wong Hing C
DirectorChief Executive Officer10% Owner
Transactions
  • Purchase

    Common Stock

    2022-09-08$2.67/sh+4,000$10,68015,300,468 total
  • Purchase

    Common Stock

    2022-09-09$2.70/sh+6,000$16,20015,306,468 total

Issuer

HCW Biologics Inc.

CIK 0001828673

Entity typeother

Related Parties

1
  • filerCIK 0001866258

Filing Metadata

Form type
4
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 3:05 PM ET
Size
6.0 KB